Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Failure To Launch: Pravachol, Zocor And The Future Of 180-Day Exclusivity

Executive Summary

Some of the most anticipated generic launches in recent years will be more limited than originally projected following court decisions creating 180-day exclusivity periods for generics of Bristol-Myers Squibb's Pravachol and Merck's Zocor

You may also be interested in...



Generic Mobic, Celexa Launches Are Not Indicative Of Price Erosion – Teva

The deep discounts seen with some recent high profile generic launches are not reflective of an eroding generic pricing environment, Teva maintains

Generic Mobic, Celexa Launches Are Not Indicative Of Price Erosion – Teva

The deep discounts seen with some recent high profile generic launches are not reflective of an eroding generic pricing environment, Teva maintains

AstraZeneca Rides Wave Of Crestor Data; Is Pfizer Facing Lipitor Wipeout?

Wall Street appears to feel that AstraZeneca has weathered the run up to the launch of generic statins far better than Pfizer

Related Content

UsernamePublicRestriction

Register

LL1135645

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel